KEGG   Homo sapiens (human): 2885
2885              CDS       T01001                                 
(RefSeq) growth factor receptor bound protein 2
K04364  growth factor receptor-bound protein 2
hsa  Homo sapiens (human)
hsa01521  EGFR tyrosine kinase inhibitor resistance
hsa01522  Endocrine resistance
hsa04010  MAPK signaling pathway
hsa04012  ErbB signaling pathway
hsa04014  Ras signaling pathway
hsa04062  Chemokine signaling pathway
hsa04068  FoxO signaling pathway
hsa04072  Phospholipase D signaling pathway
hsa04150  mTOR signaling pathway
hsa04151  PI3K-Akt signaling pathway
hsa04380  Osteoclast differentiation
hsa04510  Focal adhesion
hsa04540  Gap junction
hsa04550  Signaling pathways regulating pluripotency of stem cells
hsa04630  JAK-STAT signaling pathway
hsa04650  Natural killer cell mediated cytotoxicity
hsa04660  T cell receptor signaling pathway
hsa04662  B cell receptor signaling pathway
hsa04664  Fc epsilon RI signaling pathway
hsa04714  Thermogenesis
hsa04722  Neurotrophin signaling pathway
hsa04910  Insulin signaling pathway
hsa04912  GnRH signaling pathway
hsa04915  Estrogen signaling pathway
hsa04917  Prolactin signaling pathway
hsa04926  Relaxin signaling pathway
hsa04935  Growth hormone synthesis, secretion and action
hsa05034  Alcoholism
hsa05160  Hepatitis C
hsa05161  Hepatitis B
hsa05163  Human cytomegalovirus infection
hsa05165  Human papillomavirus infection
hsa05200  Pathways in cancer
hsa05203  Viral carcinogenesis
hsa05205  Proteoglycans in cancer
hsa05206  MicroRNAs in cancer
hsa05207  Chemical carcinogenesis - receptor activation
hsa05208  Chemical carcinogenesis - reactive oxygen species
hsa05210  Colorectal cancer
hsa05211  Renal cell carcinoma
hsa05213  Endometrial cancer
hsa05214  Glioma
hsa05215  Prostate cancer
hsa05220  Chronic myeloid leukemia
hsa05221  Acute myeloid leukemia
hsa05223  Non-small cell lung cancer
hsa05224  Breast cancer
hsa05225  Hepatocellular carcinoma
hsa05226  Gastric cancer
hsa05231  Choline metabolism in cancer
nt06162  Hepatitis B virus (HBV)
nt06163  Hepatitis C virus (HCV)
nt06164  Kaposi sarcoma-associated herpesvirus (KSHV)
nt06166  Human papillomavirus (HPV)
nt06167  Human cytomegalovirus (HCMV)
nt06170  Influenza A virus (IAV)
nt06210  ERK signaling (cancer)
nt06213  Other RAS signaling (cancer)
nt06214  PI3K signaling (cancer)
nt06260  Colorectal cancer
nt06261  Gastric cancer
nt06262  Pancreatic cancer
nt06263  Hepatocellular carcinoma
nt06264  Renal cell carcinoma
nt06265  Bladder cancer
nt06266  Non-small cell lung cancer
nt06268  Melanoma
nt06270  Breast cancer
nt06271  Endometrial cancer
nt06273  Glioma
nt06274  Thyroid cancer
nt06275  Acute myeloid leukemia
nt06276  Chronic myeloid leukemia
nt06324  GHRH-GH-IGF signaling
nt06526  MAPK signaling
nt06530  PI3K signaling
N00001  EGF-EGFR-RAS-ERK signaling pathway
N00002  BCR-ABL fusion kinase to RAS-ERK signaling pathway
N00003  Mutation-activated KIT to RAS-ERK signaling pathway
N00004  Duplication or mutation-activated FLT3 to RAS-ERK signaling pathway
N00005  Mutation-activated MET to RAS-ERK signaling pathway
N00006  Amplified EGFR to RAS-ERK signaling pathway
N00011  Mutation-activated FGFR3 to RAS-ERK signaling pathway
N00014  Mutation-activated EGFR to RAS-ERK signaling pathway
N00015  PDGF-PDGFR-RAS-ERK signaling pathway
N00016  PDGF-overexpression to RAS-ERK signaling pathway
N00018  Amplified PDGFR to RAS-ERK signaling pathway
N00019  FGF-FGFR-RAS-ERK signaling pathway
N00020  Amplified FGFR to RAS-ERK signaling pathway
N00021  EGF-ERBB2-RAS-ERK signaling pathway
N00022  ERBB2-overexpression to RAS-ERK signaling pathway
N00030  EGF-EGFR-RAS-PI3K signaling pathway
N00031  Duplication or mutation-activated FLT3 to RAS-PI3K signaling pathway
N00041  EGFR-overexpression to RAS-ERK signaling pathway
N00096  EGF-EGFR-RAS-RASSF1 signaling pathway
N00103  EGF-EGFR-RAS-RalGDS signaling pathway
N00215  KITLG-KIT-RAS-ERK signaling pathway
N00216  HGF-MET-RAS-ERK signaling pathway
N00217  FLT3LG-FLT3-RAS-ERK signaling pathway
N00218  FLT3LG-FLT3-RAS-PI3K signaling pathway
N00229  TGFA-EGFR-RAS-ERK signaling pathway
N00230  TGFA-overexpression to RAS-ERK signaling pathway
N00233  IGF-IGF1R-RAS-ERK signaling pathway
N00235  IGF2-overexpression to RAS-ERK signaling pathway
N00237  IGF1R-overexpression to RAS-ERK signaling pathway
N00246  HGF-overexpression to RAS-ERK signaling pathway
N00248  MET-overexpression to RAS-ERK signaling pathway
N00252  Amplified ERBB2 to RAS-ERK signaling pathway
N00259  Amplified MET to RAS-ERK signaling pathway
N00274  HCV NS5A to RAS-ERK signaling pathway
N00276  EGF-overexpression to RAS-ERK signaling pathway
N00277  EREG-EGFR-RAS-ERK signaling pathway
N00278  EREG-overexpression to RAS-ERK signaling pathway
N00279  AREG-EGFR-RAS-ERK signaling pathway
N00280  AREG-overexpression to RAS-ERK signaling pathway
N00367  HPV E5 to EGFR-RAS-ERK signaling pathway
N00386  HCMV gB to PDGFR-RAS-ERK signaling pathway
N00513  Mutation-activated EGFR to RAS-ERK signaling pathway
N00538  Ca2+-PYK2-RAS-ERK signaling pathway
N00540  HBV HBx to RAS-ERK signaling pathway
N00542  EGF-EGFR-RAS-JNK signaling pathway
N01062  Mutation-activated MET to RAS-ERK signaling pathway
N01354  BPA to RAS-ERK signaling pathway
N01360  P4-PR-RAS-ERK signaling pathway
N01361  P4/MPA to PR-RAS-ERK signaling pathway
N01592  GF-RTK-RAS-ERK signaling pathway
N01595  Regulation of GF-RTK-RAS-ERK signaling pathway, adaptor proteins
N01658  GF-RTK-RAS-PI3K signaling pathway
Drug target
Prexigebersen: D11165
KEGG Orthology (KO) [BR:hsa00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    2885 (GRB2)
   04012 ErbB signaling pathway
    2885 (GRB2)
   04014 Ras signaling pathway
    2885 (GRB2)
   04630 JAK-STAT signaling pathway
    2885 (GRB2)
   04068 FoxO signaling pathway
    2885 (GRB2)
   04072 Phospholipase D signaling pathway
    2885 (GRB2)
   04151 PI3K-Akt signaling pathway
    2885 (GRB2)
   04150 mTOR signaling pathway
    2885 (GRB2)
 09140 Cellular Processes
  09144 Cellular community - eukaryotes
   04510 Focal adhesion
    2885 (GRB2)
   04540 Gap junction
    2885 (GRB2)
   04550 Signaling pathways regulating pluripotency of stem cells
    2885 (GRB2)
 09150 Organismal Systems
  09151 Immune system
   04650 Natural killer cell mediated cytotoxicity
    2885 (GRB2)
   04660 T cell receptor signaling pathway
    2885 (GRB2)
   04662 B cell receptor signaling pathway
    2885 (GRB2)
   04664 Fc epsilon RI signaling pathway
    2885 (GRB2)
   04062 Chemokine signaling pathway
    2885 (GRB2)
  09152 Endocrine system
   04910 Insulin signaling pathway
    2885 (GRB2)
   04912 GnRH signaling pathway
    2885 (GRB2)
   04915 Estrogen signaling pathway
    2885 (GRB2)
   04917 Prolactin signaling pathway
    2885 (GRB2)
   04926 Relaxin signaling pathway
    2885 (GRB2)
   04935 Growth hormone synthesis, secretion and action
    2885 (GRB2)
  09156 Nervous system
   04722 Neurotrophin signaling pathway
    2885 (GRB2)
  09158 Development and regeneration
   04380 Osteoclast differentiation
    2885 (GRB2)
  09159 Environmental adaptation
   04714 Thermogenesis
    2885 (GRB2)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    2885 (GRB2)
   05206 MicroRNAs in cancer
    2885 (GRB2)
   05205 Proteoglycans in cancer
    2885 (GRB2)
   05207 Chemical carcinogenesis - receptor activation
    2885 (GRB2)
   05208 Chemical carcinogenesis - reactive oxygen species
    2885 (GRB2)
   05203 Viral carcinogenesis
    2885 (GRB2)
   05231 Choline metabolism in cancer
    2885 (GRB2)
  09162 Cancer: specific types
   05210 Colorectal cancer
    2885 (GRB2)
   05225 Hepatocellular carcinoma
    2885 (GRB2)
   05226 Gastric cancer
    2885 (GRB2)
   05214 Glioma
    2885 (GRB2)
   05221 Acute myeloid leukemia
    2885 (GRB2)
   05220 Chronic myeloid leukemia
    2885 (GRB2)
   05211 Renal cell carcinoma
    2885 (GRB2)
   05215 Prostate cancer
    2885 (GRB2)
   05213 Endometrial cancer
    2885 (GRB2)
   05224 Breast cancer
    2885 (GRB2)
   05223 Non-small cell lung cancer
    2885 (GRB2)
  09172 Infectious disease: viral
   05161 Hepatitis B
    2885 (GRB2)
   05160 Hepatitis C
    2885 (GRB2)
   05163 Human cytomegalovirus infection
    2885 (GRB2)
   05165 Human papillomavirus infection
    2885 (GRB2)
  09165 Substance dependence
   05034 Alcoholism
    2885 (GRB2)
  09176 Drug resistance: antineoplastic
   01521 EGFR tyrosine kinase inhibitor resistance
    2885 (GRB2)
   01522 Endocrine resistance
    2885 (GRB2)
 09180 Brite Hierarchies
  09182 Protein families: genetic information processing
   04131 Membrane trafficking [BR:hsa04131]
    2885 (GRB2)
Membrane trafficking [BR:hsa04131]
  Clathrin-mediated endocytosis
   Receptor tyrosine kinase (RTK) adaptor proteins
    2885 (GRB2)
Pfam: SH3_1 SH3_9 SH3_2 SH2 SH3_10 SH3_3 SH2_2 DUF5093 hSH3 SH3_4
Other DBs
NCBI-GeneID: 2885
NCBI-ProteinID: NP_002077
OMIM: 108355
HGNC: 4566
Ensembl: ENSG00000177885
UniProt: P62993 B0LPF3
AA seq 217 aa
NT seq 654 nt   +upstreamnt  +downstreamnt

DBGET integrated database retrieval system